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        The innate immune system is evolutionally con-
served, and it is the fi  rst line of the defensive 
mechanisms for protecting the host from invad-
ing microbial pathogens (  1  ). Innate immune cells, 
including macrophages and dendritic cells, ex-
press a series of receptors known as Toll-like 
receptors (TLRs), which bind to highly con-
served sequences expressed by microorganisms 
(  2, 3  ). LPS is an integral cell wall component of 
Gram-negative bacteria, and can provoke a life-
threatening condition called endotoxic shock. 
The infl  ammatory response to LPS is mediated 
mainly by a receptor complex composed of LPS-
binding protein CD14 and TLR4 (  4  ). Upon 
activation of TLR4, the cytoplasmic domains 
recruit signal adaptor molecules, such as MyD88 
and Trif, which, in turn, trigger a cascade of 
signaling events leading to the activation of 
MAPKs and I    B kinases (IKKs), as well as the 
downstream transcription factors AP-1, NF-    B, 
and IRF3. Activation of NF-    B and mito-
gen-activated protein kinases (MAPKs) by the 
MyD88-dependent pathway is essential for the 
transcription of a variety of proinfl  ammatory 
cytokines, including TNF     and IL-6, whereas 
the initial induction of type I IFN, e.g., IFN-    , 
is largely dependent on Trif-mediated IRF3 
activation (  5  ). These proinfl  ammatory cytokines 
can, in turn, stimulate the release of secondary 
mediators, which, if not properly controlled, 
may ultimately lead to dysfunction of multiple 
vital organs. 
  The optimal type and strength of the innate 
immune response can be regulated through a 
balance of activating and inhibitory signals that 
are delivered by receptors on the surface of cells 
of the innate immune system (  6  ). One such 
group of cell-surface receptors is the signal reg-
ulatory protein (SIRP) family. The fi  rst  and 
best-characterized member of the SIRP family, 
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  Activation of the mitogen-activated protein kinases (MAPKs) and nuclear factor     B 
(NF-    B) cascades after Toll-like receptor (TLR) stimulation contributes to innate immune 
responses. Signal regulatory protein (SIRP)     , a member of the SIRP family that is abundantly 
expressed in macrophages, has been implicated in regulating MAPK and NF-    B signaling 
pathways. In addition, SIRP     can negatively regulate the phagocytosis of host cells by 
macrophages, indicating an inhibitory role of SIRP     in innate immunity. We provide evi-
dences that SIRP     is an essential endogenous regulator of the innate immune activation 
upon lipopolysaccharide (LPS) exposure. SIRP     expression was promptly reduced in macro-
phages after LPS stimulation. The decrease in SIRP     expression levels was required for 
initiation of LPS-induced innate immune responses because overexpression of SIRP     re-
duced macrophage responses to LPS. Knockdown of SIRP     caused prolonged activation of 
MAPKs and NF-    B pathways and augmented production of proinfl  ammatory cytokines and 
type I interferon (IFN). Mice transferred with SIRP    -depleted macrophages were highly 
susceptible to endotoxic shock, developing multiple organ failure and exhibiting a remark-
able increase in mortality. SIRP     may accomplish this mainly through its association and 
sequestration of the LPS signal transducer SHP-2. Thus, SIRP     functions as a biologically 
important modulator of TLR signaling and innate immunity. 2720 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
empty vector, introduction of shRNA or SIRP     gene had 
little eff  ect on cell growth during the time period examined 
(  Fig. 1 B  ). TLR stimulation activates IKKs and all three major 
subgroups of MAPK: c-Jun NH  2  -terminal kinase (JNK), p38 
MAPK, and extracellular signal  –  related kinase (ERK) (  2, 3  ). 
In response to LPS, KD macrophages were found to exhibit en-
hanced phosphorylation of p38, JNK, ERK, and I   B    , whereas 
overexpression of SIRP     resulted in reduction of these sig-
naling pathways in RAW cells (  Fig. 1 C  ). Furthermore, tran-
sient transfection of siRNA directed against SIRP     into 
thioglycollate-elicited peritoneal macrophages from C57BL/6 
mice (  Fig. 1 D  ) also resulted in higher activation of p38, JNK, 
ERK, and I    B     compared with that in macrophages trans-
fected with negative control siRNA upon LPS stimulation 
(  Fig. 1 E  ). Because AP-1 and NF-    B transcription factors are 
known targets of LPS-activated MAPKs and IKKs, we then 
examined whether SIRP     aff  ects AP-1 and NF-    B activities. 
As revealed by a luciferase reporter assay, there were substantial 
increases in AP-1 and NF-    B activities in SIRP    -KD macro-
phages after LPS stimulation (  Fig. 1 F  ). Conversely, introduc-
tion of WT SIRP     attenuated activation of AP-1 and NF-    B 
reporter genes by LPS stimulation. These fi  ndings demonstrate 
that SIRP     negatively regulates LPS signaling by suppressing 
the MAPKs and NF-    B pathways in macrophages. 
  SIRP     knockdown alters the pattern of cytokine production 
in LPS-stimulated macrophages 
  Because MAPKs and NF-    B signaling are pivotal in modu-
lating innate immune responses, we investigate whether 
SIRP     directly controls cytokine production in macrophages 
upon LPS treatment. SIRP    -KD, -OV, and -VT macro-
phages were stimulated with various concentrations of LPS 
for 12 h to determine the production of cytokines or for 
24 h for the nitric oxide (NO) in the conditioned medium. 
In response to LPS stimulation, SIRP    -KD macrophages 
produced substantially more TNF    , IL-6, and NO than 
SIRP    -OV and -VT macrophages (  Fig. 2 A  ).   As expected, 
SIRP    -OV cells produced the least TNF    , IL-6, and NO at 
any of the doses examined. To exclude the possibility that 
SIRP    -KD macrophages might be compensatorily activated, 
thioglycollate-elicited peritoneal macrophages from C57BL/6 
mice were used to assess the role of SIRP     in cytokine pro-
duction in primary macrophages. Similar to what was ob-
served for SIRP    -KD macrophages, peritoneal macrophages 
transfected with SIRP     siRNA also mounted a more robust 
TNF    , IL-6, and NO production than did negative control 
siRNA upon various doses of LPS stimulation (  Fig. 2 B  ), 
suggesting that no compensatory activation of macrophages 
occurs under SIRP    -KD conditions. 
  To study the eff  ects of SIRP     on the production of com-
prehensive infl  ammatory cytokines, SIRP    -KD and -OV 
cells were stimulated with LPS for 12 h, and the conditioned 
medium was subjected to an antibody array of 40 mouse in-
fl  ammatory cytokines. As shown in   Fig. 2 C  , a substantial 
number of proinfl  ammatory cytokines, including IL-6, TNF   , 
MCP-1, MIP-1    , RANTES, and GCSF, were dramatically 
SIRP    , is especially abundant in innate immune cells, includ-
ing macrophages and dendritic cells (  7, 8  ). The extracellular 
region of SIRP    is heavily glycosylated, and it has been shown 
to bind to either widely expressed transmembrane ligand 
CD47 (  9  ) or soluble ligands, such as the surfactant proteins 
A and D, which are present at high levels in the lungs (  10  ). 
Interaction of CD47 with SIRP     negatively regulates phago-
cytosis of host cells by macrophages (  11  ). Mice that lack the 
SIRP     cytoplasmic domain are thrombocytopenic, which 
apparently results from an increased rate of clearance of circu-
lating platelets (  12, 13  ). Nonopsonized erythrocytes from 
CD47      /      mice are recognized and rapidly eliminated in WT 
recipients, and they are phagocytosed by WT macrophages 
in vitro (  14  ). This strongly suggests that SIRP     acts to nega-
tively control innate immune eff  ector function. In lungs, 
ligation of SIRP     on macrophages by surfactant proteins is 
required to keep the activity of alveolar macrophages in check, 
thus preventing damage to the airways caused by proinfl  am-
matory responses (  10  ). Therefore, SIRP     induces well-char-
acterized inhibitory signals in innate immune cells that can 
largely be reconciled by the association of tyrosine phospha-
tases with the cytoplasmic region (  8, 15  ). The cytoplasmic re-
gion of SIRP     contains two immunoreceptor tyrosine-based 
inhibitory motifs with four tyrosine residues that are phos-
phorylated in response to a variety of growth factors and 
ligand binding. This phosphorylation enables recruitment of 
SHP-1 and -2 that, in turn, dephosphorylates specifi  c protein 
substrates involved in mediating various physiological eff  ects 
(  8, 16, 17  ). SIRP     has been shown to negatively or positively 
regulate MAPK signaling initiated either by tyrosine kinase  –
  coupled receptors for growth factors or by cell adhesion to 
extracellular matrix (  8, 16  ). Moreover, the expression of the 
dominant-negative form of SIRP     stimulates NF-    B activity 
and makes the cells resistant to TNF-specifi  c apoptosis (  18  ). 
However, the role of SIRP     in TLR-mediated signaling dur-
ing innate immune responses has not been defi  ned. We show 
that SIRP     plays an essential role in negatively regulating LPS 
signaling at an early stage of TLR4 activation. LPS-induced 
SIRP     reduction is required for initiation of MyD88- and 
Trif-dependent intracellular signaling pathways. Knockdown 
of SIRP     leads to augmented production of proinfl  ammatory 
cytokines and multiple organ failure, which is characteristic of 
severe sepsis after TLR activation. Thus, the expression level 
of SIRP     may represent a threshold for control of a magni-
tude of host infl  ammatory responses to microbial pathogens. 
    RESULTS   
  SIRP     knockdown enhances TLR signaling in macrophages 
  To examine SIRP     regulation of the innate immune responses 
during bacterial infection, we fi  rst constructed a short hairpin 
RNA (shRNA) vector that specifi  cally down-regulated SIRP     
and stably transfected it into RAW264.7 macrophage cells. 
RAW cells were also stably transfected with either WT SIRP     
(Myc-tagged) or an empty vector. They are referred to here as 
SIRP    -KD (knockdown), -OV (overexpression), and -VT 
(vector) macrophages, respectively (  Fig. 1 A  ).   Compared with JEM VOL. 204, October 29, 2007 
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element (ISRE) reporter activity was also increased in stably 
transfected RAW cell lines expressing shRNA for SIRP     
(  Fig. 2 G  ). Because initial induction of IFN-     is largely de-
pendent on Trif-mediated IRF3 activation, we examined the 
phosphorylation of IRF3 upon LPS challenge and found that 
SIRP     siRNA treatment evidently led to the enhanced LPS-
induced IRF3 activation in mouse peritoneal macrophages 
(  Fig. 2 H  ). Collectively, our data clearly indicate that SIRP     
regulates the expression profi  le of proinfl  ammatory cytokines 
through both MyD88- and Trif-dependent pathways. 
induced after LPS challenge. However, many antiinfl  ammatory 
cytokines, such as IL-4 and -10, were not substantially altered. 
ELISA assays confi  rmed that the production of MIP-1     and 
RANTES in the LPS-stimulated SIRP     KD macrophages was, 
indeed, considerably higher than those in the LPS-stimulated 
SIRP    -OV and -VT macrophages (  Fig. 2 D  ). 
  Interestingly, SIRP     knockdown also substantially raised 
LPS-induced IFN-     production and mRNA expression in 
either RAW cell line or mouse peritoneal macrophages (  Fig. 
2, E and F  ). In addition, the interferon-sensitive response 
  Figure 1.     Increased signaling in SIRP     knockdown macrophages upon LPS stimulation. (A) RAW cells were stably transfected with empty vector 
or constructs containing shRNA specifi  c for SIRP     or Myc-tagged SIRP    , and SIRP     expression levels were detected by Western blotting. (B) Cell prolif-
eration of stable RAW cells was measured using CCK-8 assay at the indicated times. Data are the mean      the SEM of triplicates from an experiment that 
was repeated a total of three times with similar results. (C) Strongly increased signaling in SIRP    -KD macrophage cell lines. 5      10 5   cells/well  SIRP  -KD, 
-OV, and -VT RAW cells were stimulated with 10 ng/ml LPS for the indicated times. Cell lysates were prepared and blotted with the indicated antibodies. 
(D) Peritoneal macrophages were transiently transfected with siRNA (D10 and/or D12) targeting SIRP     or irrelevant control siRNA. The reduction of SIRP    
expression was demonstrated by Western blotting. (E) 1.5      10 5   cells/well peritoneal macrophages from C57BL/6 mice were transfected with control or 
SIRP     siRNA, and then stimulated with 10 ng/ml of LPS for the indicated minutes. Cell lysates were blotted as mentioned in C. (F) 1      10 5   SIRP  -KD,  -OV, 
and -VT cells were transfected with the NF-    B or AP-1 reporter plasmids (0.2     g), together with the control plasmid pRL-TK (0.02     g), and treated with 
various doses of LPS for 6 h, and then luciferase activities were detected. Data are expressed as relative fold activation to that of nonstimulated (  −  ) sets. 
*, P   	   0.05; **, P   	   0.01 (OV or KD different from VT).     2722 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
stained with a fl  uorescent vital dye, SP-DiI, which was sys-
temically delivered in vivo. The cells were analyzed by light 
and fl  uorescent microscopy in frozen sections 24 h after injec-
tion. As shown in   Fig. 3 A  , a large number of the injected 
RAW cells were found in the normal spleen, liver, and lung 
tissues, which is a typical distribution pattern for host-derived 
macrophages.   Furthermore, the reconstituted mice showed a 
similar survival rate to the control normal mice after lethal 
dose challenge with LPS (  Fig. 3 B  ). These results may support 
  Transferring with SIRP    -KD macrophages increases 
susceptibility of mice to lethal LPS shock 
  Because SIRP    -KD macrophages exhibited a marked eleva-
tion in TNF    , which plays an important role in the pathogen-
esis of septic shock (  19  ), we asked whether mice transfered 
with SIRP    -KD macrophages were more susceptible to LPS-
induced toxicity. To determine whether RAW cells were 
capable of reconstituting macrophage-depleted allogeneic 
BALB/c mice (GdCl  3   pretreatment), RAW264.7 cells were 
  Figure 2.     Increased cytokine production of SIRP     knockdown macrophages upon LPS stimulation in vitro. (A) 5      10 5   cells/well  SIRP  -KD,  -OV, 
and -VT cells were treated with different amounts of LPS for 12 or 24 h, after which culture supernatants were harvested for measurement of TNF   ,  IL-6, 
and NO production. (B) Cytokine production by LPS-challenged peritoneal macrophages. 3      10 5   cells/well transfected with SIRP     siRNA or negative 
control oligonucleotides. (C) Cytokine antibody array analysis of LPS-treated cytokine production in SIRP    -KD and -OV cells. Cells were primed with 
100 ng/ml LPS for 12 h, after which culture supernatants were harvested for the cytokine antibody array analysis. The density value of each test sample was 
normalized to control spots on the same membrane graphed. (D) 5      10 5   cells/well  SIRP   -KD, -OV, and -VT cells were primed with different amount of 
LPS for 12 h, after which culture supernatants were harvested for measurement of MIP-1     and RANTES by ELISA. (E) IFN-     production after LPS chal-
lenge in stable RAW cell lines (left) or in peritoneal macrophages transfected with SIRP     siRNA (right) were analyzed as mentioned above. (F) Cells were 
incubated with 100 ng/ml of LPS for the indicated time, and IFN-     mRNA levels were determined by quantitative real-time PCR. (G) Cells were transfected 
with the ISRE reporter plasmid (0.2     g), together with the control plasmid pRL-TK (0.02     g), and treated with various doses of LPS for 6 h, and then lucif-
erase activities were detected. The data are representative of three independent experiments with similar results. (H) Peritoneal macrophages from 
C57BL/6 mice were transfected with control or SIRP     siRNA and then stimulated with 10 ng/ml of LPS for the indicated minutes. Cell lysates were blotted 
with anti  –  phospho-IRF3 and anti-GAPDH antibodies. Data are the mean      the SEM of three independent experiments. *, P   	   0.05; **, P   	   0.01 (OV or KD 
different from VT in A, D, F, and G).      JEM VOL. 204, October 29, 2007 
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TLR9 apparently occurred independently of SIRP     expression. 
We also performed these studies with peritoneal macrophages 
transiently transfected with synthetic SIRP     siRNA and ob-
tained similar results (  Fig. 4 C  ). Thus, SIRP     seems to regu-
late the magnitude and duration at the early   “  time window  ”   
of TLR-induced responses independently of previously de-
scribed endotoxin tolerance mechanisms (  20  ). 
  LPS-induced SIRP     reduction contributes 
to macrophage activation 
  To understand the cellular mechanisms by which SIRP     con-
trols LPS signaling, we fi  rst examined whether SIRP     could 
modulate the expression of TLR4, which is a functional recep-
tor for LPS. By using immunoblot assay, we measured TLR4 
expression in SIRP    -KD, -OV, and -VT macrophages, or in 
peritoneal macrophages from C57BL/6 mice transfected with 
SIRP     siRNA or negative control siRNA with or without LPS 
exposure for 12 h, and we found no detectable diff  erence in 
TLR4 levels between the cells examined (  Fig. 5 A  ).   We next 
analyzed SIRP     protein and RNA levels after an initial LPS 
treatment in mouse macrophage cell lines (RAW 264.7 and 
J774A.1), as well as in mouse peritoneal macrophages.   Fig. 5 B   
shows a pattern of rapid and persistent down-regulation 
of SIRP     protein after LPS treatment in a time- and dose-
  dependent manner. Quantitative real-time PCR analysis further 
showed that there was an approximately threefold reduction of 
SIRP     RNA expression after 15 min of exposure to LPS, and 
that SIRP     mRNA remained lower after 24 h (  Fig. 5 C  ). To 
determine whether the reduction in SIRP     expression induced 
by LPS was also attributable to an increased rate of degradation, 
we examined the eff  ects of inhibitors of protein degradation by 
lysosomes or the proteasome. MG132, which is a reversible pep-
tide aldehyde that blocks proteasomal activity, had no marked 
eff  ect on the ability of LPS to suppress SIRP     expression. 
In contrast, prior treatment of RAW cells with chloroquine or 
NH  4  Cl, both of which inhibit lysosomal function, substantially 
attenuated the eff  ect of LPS. On the other hand, treatment with 
cycloheximide (CHX) alone considerably suppressed the levels 
of SIRP     protein, and LPS stimulation in the presence of CHX 
further down-regulated SIRP     expression (  Fig. 5 D  ). Collec-
tively, these data clearly indicate that, in addition to transcrip-
tional repression of SIRP     expression, LPS also induces the 
degradation of SIRP     by the lysosome, thus contributing to the 
loss of SIRP     protein in macrophages after LPS stimulation. 
  To determine the upstream signals responsible for the 
reduction of SIRP    , we examined the expression of SIRP     
in mice lacking TLR4 (C57BL/10ScCr) or in mice with a 
missense mutation of TLR4 (C3H/HeJ) (  21  ). After LPS treat-
ment, the reduction of SIRP     expression was not observed in 
peritoneal macrophages from either TLR4 knockout or mu-
tant mice, suggesting that TLR4 is required for LPS-induced 
SIRP     down-regulation (  Fig. 5 E  ). Interestingly, SIRP     pro-
tein levels were constitutively higher in peritoneal macro-
phages from C57BL/10ScCr or C3H/HeJ mice than in cells 
from control mice, indicating that basal TLR4 signaling activ-
ity is necessary for controlling the expression level of SIRP    . 
the feasibility of this model system. Next, age- and sex-matched 
cohorts of mice pretreated with GdCl  3   for 24 h were injected i.v 
with SIRP    -KD, -OV, or -VT cells; after an additional 24 h, 
they were injected i.p. either with vehicle (PBS) or LPS. Sur-
vival of these animals was monitored over 4  –  5 d. As shown in 
  Fig. 3 C  , none of the SIRP    -KD, -OV, and -VT mice injected 
with PBS showed a diff  erence on survival. However, at a LPS 
dose of 20 mg/kg body weight, mortality was observed within 
14 h after LPS challenge for KD mice. By 24 h,   
  50% of KD 
mice had died, whereas the fi  rst mortality for VT mice occurred 
at 24 h. Although 85% death was noted for KD mice by the end 
of the experiment (120 h), only 26 and 35% of the OV and VT 
mice had died. Therefore, KD mice were more susceptible to 
LPS-induced lethality. 
  Endotoxic shock is mediated by an overproduction of pro-
infl  ammatory cytokines, including TNF     and IL-6. To exam-
ine whether SIRP     controls cytokine release in response to 
LPS stimulation in vivo, we measured levels of various cyto-
kines in the serum from mice after 3 h of LPS challenge. In the 
absence of LPS challenge, serum levels of TNF     and IL-6 
were at a very low level. In response to LPS challenge, serum 
TNF     and IL-6 levels in KD mice were substantially elevated 
by   
  3  –  4 and 1.5  –  2 times, respectively, of those in OV and VT 
mice (  Fig. 3 D  ). 
  To examine the eff  ects of SIRP     on the function of key 
organs, SIRP    -KD, -OV, and -VT mice were challenged 
with LPS at a dose of 10 mg/kg body weight and killed 24 h 
after LPS injection. As shown in   Fig. 3 E  , KD mice challenged 
with LPS showed gross organ failure and severe infl  ammatory 
infi  ltrates in lung and liver, compared with OV and VT mice. 
Collectively, our results indicate that SIRP    -KD mice are 
highly susceptible to the development of multiple organ failure 
syndromes after LPS administration, and that SIRP     is required 
for the restriction of macrophage responses to LPS in vivo. 
  Endotoxin tolerance is SIRP     independent 
  The aforementioned results, fi  nding that SIRP     down-regu-
lated LPS-induced biological responses, prompted us to in-
vestigate whether SIRP     is also important for mediating 
endotoxin tolerance, a transient state of LPS refractoriness 
after the initial, nonlethal exposure to LPS. To determine 
whether SIRP     regulates the production of proinfl  ammatory 
cytokines after LPS pretreatment, we fi  rst treated SIRP    -
KD, -OV, and -VT macrophages with LPS for 24 h, after 
which we assessed IL-6 and TNF     production during a sub-
sequent 12-h LPS treatment, or 24-h treatment for NO. 
SIRP    -KD cells substantially elaborated increased amounts 
of TNF    , IL-6, and NO during the fi  rst 12 h after exposure 
to LPS (  Fig. 4 A  ).   Their production by all SIRP    -KD, -OV, 
and -VT macrophages was considerably reduced after 24 h of 
LPS pretreatment, indicating that SIRP     is not required for 
LPS-induced down-regulation of cytokine production. Simi-
larly, stimulation of cells with CpG or LPS for 24 h, followed 
by a second 12 or 24 h of LPS or CpG treatment, also resulted 
in decreased IL-6, TNF    , and NO production by all cells 
(  Fig. 4 B  ), suggesting that cross-tolerance between TLR4 and 2724 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
  Figure 3.     Increased response in mice transfered with SIRP     knockdown macrophages upon LPS stimulation in vivo. (A) Reconstitution of macro-
phage-depleted mice with RAW264.7 cells. Fluorescent dye-labeled RAW264.7 cells were injected i.v. into GdCl  3  -treated Balb/C mice. Mouse organs 
(spleen, liver, and lung) were preserved for fl  uorescence microscopy analysis. Numerous injected cells are detectable in lung, spleen, and liver. Tissue mor-
phology is visualized by hematoxylin staining. (B) Similar lethality in mice reconstituted with RAW264.7 cells challenged with LPS. Age- and sex-matched 
cohorts of mice (  n    6) were pretreated with GdCl  3   (10 mg/kg of body weight) or PBS and, 24 h later, were i.v. injected with RAW264.7 cells (10  7 /each)  or 
PBS, respectively. Another 24 h later, mice were i.p. administered with 25 mg LPS/kg of body weight, and lethality was observed over 60 h after this challenge. JEM VOL. 204, October 29, 2007 
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LPS treatment aff  ected tyrosine phosphorylation of SIRP     and 
its association with SHP-1 and -2 in macrophages. RAW264.7 
cells were stimulated with LPS, and the endogenous SIRP     
was immunoprecipitated and subjected to immunoblot with 
respective antibodies. As shown in   Fig. 6 A  , LPS treat-
ment induced tyrosine phosphorylation of SIRP    , but failed 
  SIRP     is activated by LPS and binds constitutively to SHP-1 
and -2 
  SIRP     is a surface receptor containing immunoreceptor tyro-
sine  –  based inhibitory motif domains that are known to exert 
inhibitory functions through the recruitment of phosphatase 
enzymes SHP-1 and -2 (  22  ). Thus, we investigated whether 
  Figure 4.     SIRP     is not required for endotoxin tolerance. (A) 5      10 5   cells/well  SIRP   -KD, -OV, and -VT cells were untreated or tolerized with 100 ng/ml LPS 
for 24 h, washed, and rechallenged with 100 ng/ml LPS. After 12 h of incubation, the media were assessed for TNF     and IL-6, and for NO levels after 24 h. 
Data are presented as the mean      the SEM of 3  –  8 independent experiments. (B) 5      10 5   cells/well  SIRP   -KD, -OV, and -VT cells were tolerized with LPS 
or CpG for 24 h, washed, and rechallenged with the indicated doses of LPS or CpG. TNF    , IL-6, and NO levels were determined as described in A. (C) 3      10 5  
cells/well peritoneal macrophages from C57BL/6 mice were transfected with either control or SIRP     siRNA. 24 h later, cells were tolerized with LPS or CpG 
for 24 h, washed, and rechallenged with the indicated doses of LPS or CpG. TNF    , IL-6, and NO levels were determined as described in A.     
The data are representative of two independent experiments with similar results. (C) More lethality in mice transfered with SIRP    -KD cells challenged 
with LPS. Age- and sex-matched cohorts of mice (  n    7) were pretreated with GdCl  3   (10 mg/kg of body weight), and 24 h later were i.v. injected with 
SIRP    -KD, -OV, and -VT cells (10  7  /each). Another 24 h later, mice were i.p. administered with PBS or 20 mg LPS/kg of body weight, and lethality was ob-
served over 120 h after this challenge. The data are representative of two independent experiments with similar results. (D) Sera from mice pretreated as 
described in A and injected with PBS or LPS (10 mg/kg of body weight) were collected at 3 h after the challenge, and IL-6 and TNF     levels were measured 
by ELISA. Data show the mean      the SEM for three mice from each group. *, P   	   0.05; **, P   	   0.01 (OV or KD different from VT). (E) Severe multiple organ 
failure in mice transfered with SIRP    -KD cells challenged with LPS. Representative images of lung and liver with histological sections from mice pre-
treated as described in C and killed at 24 h after LPS administration (10 mg/kg weight body). Bars, 100    m.   2726 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
In addition, PP  2   also blocked LPS-induced SIRP     phosphoryl-
ation, indicating that such phosphorylation of SIRP     is mainly 
mediated by Src kinases (  Fig. 6 C  ). 
  SHP-1 is generally considered a negative signal transducer, 
whereas SHP-2 is considered a positive one (  25  ). However, 
the precise role of each enzyme in shared signaling pathways 
during innate immune activation is not well defi  ned. To ex-
amine their roles in LPS-mediated signaling, SHP-1 and -2 
expression were separately knocked down by siRNAs in 
to enhance SHP-1 and -2 recruitment.   Interestingly, SHP-1 
and -2 were found to be constitutively associated with SIRP     
in macrophages (  Fig. 6 A  ), which coincided with the results 
of previous studies (  23, 24  ). However, treatment of RAW 
cells with either the Src-specifi  c inhibitor PP  2   or universal 
tyrosine kinase inhibitor Genistein nearly abrogated the con-
stitutive association of SIRP     with SHP-1 or -2, which sug-
gests that the basal association of SHP proteins is dependent 
on the undetectable phosphorylation of SIRP     (  Fig. 6 B  ). 
  Figure 5.     LPS-induced SIRP     reduction contributes to macrophage activation. (A) Stable RAW-derived cell lines (left) and peritoneal macro-
phages transiently transfected with either control or SIRP     siRNA (right) were incubated with or without 100 ng/ml LPS for 12 h. Immunoblots with a 
TLR4-specifi  c antibody were performed. (B) Down-regulation of SIRP     protein levels in macrophages after LPS treatment. Mouse macrophage cell lines 
RAW264.7 and J774A.1, as well as peritoneal macrophages from C57BL/6 mice, were incubated with 100 ng/ml LPS for the indicated times (left) or with 
the indicated LPS doses for 12 h (right), and SIRP     protein expression was determined by Western blotting. PWC, peritoneal macrophages. (C) Down-
regulation of SIRP     mRNA levels in macrophages after LPS treatment. RAW264.7 macrophages were incubated with 100 ng/ml of LPS for the indicated 
time (left), or with the indicated LPS doses for 12 h (right), and SIRP     mRNA levels were determined by quantitative real-time PCR. (D) The reduction of 
SIRP     protein level involves protein degradation. RAW264.7 cells were incubated for 2 h at 37  °  C in the absence or presence of 100    M  chloroquine, 
10 mM NH  4  Cl, 40     M MG132, or 50     g/ml CHX, after which they were treated with or without 100 ng/ml LPS for 5 h and subjected to Western blot analy-
sis using SIRP   -specifi  c antibody. (E) TLR4 is essential for the down-regulation of SIRP    . Peritoneal macrophages from TLR4 KO (C57BL/10ScCr) and 
littermate WT1 (C57BL/10snj) mice or TLR4 mutant (C3H/HeJ) and littermate WT2 (C3H/Heouj) mice were incubated with 100 ng/ml LPS for the indicated 
times, and SIRP     protein expression was determined by Western blot analysis.     JEM VOL. 204, October 29, 2007 
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p38, whereas knockdown of SHP-2 slightly reduced their 
activities (  Fig. 6 G  ). 
  To elucidate whether SHP-1 and -2 contribute to the 
inhibitory function of SIRP     in macrophage activation, perito-
neal macrophages were cotransfected with SIRP     and SHP-1 
siRNAs or SIRP     and SHP-2 siRNAs to eliminate both pro-
teins simultaneously. After LPS stimulation, the conditioned 
medium was analyzed for cytokine production. As shown in 
  Fig. 6 H , knockdown of SHP-1, together with SIRP   , slightly 
increased the production of TNF     and IL-6 more than 
knockdown of SIRP     alone, suggesting a synergetic role of 
peritoneal macrophages (  Fig. 6 D  ) with subsequent LPS 
treatment, and the production of TNF     and IL-6 was ana-
lyzed using ELISA assay. As expected, knockdown of SHP-1 
caused an     20% increase in cytokine production, whereas 
knockdown of SHP-2 resulted in a nearly twofold lower 
production of TNF     and IL-6 (  Fig. 6 E  ). Further analysis 
of IFN-     production in SHP-1 and -2 siRNA-transfected 
cells reveals that SHP-2 plays a critical role in positive regu-
lation of LPS-induced Trif signaling, whereas SHP-1 has 
no marked eff  ect on the pathway (  Fig. 6 F  ). In addition, 
knockdown of SHP-1 enhanced the activation of ERK and 
  Figure 6.     SIRP     inhibits LPS signaling mainly through sequestration of SHP-2. (A) RAW264.7 cells were stimulated with LPS for the indicated 
time, immunoprecipitated for endogenous SIRP    , and probed with an antiphosphotyrosine antibody. Immunoblots were also probed with anti-SIRP   , 
  –  SHP-1, and   –  SHP-2 antibodies. (B) Basal association of SHP proteins is dependent on SIRP     phosphorylation. RAW264.7 cells were treated with vehicle 
(DMSO), 10     M PP2, or 50     M genistein for 1 h, and then subjected to immunoprecipitation and immunoblot, as in A. (C) TLR4-induced SIRP     phos-
phorylation is mediated by Src kinases. RAW264.7 cells were stimulated with LPS for 15 min in the absence or presence of DMSO, PP2, or genistein, and 
then subjected to immunoprecipitation and immunoblotting as in A. (D) Western blot analysis demonstrates the effects of siRNAs that specifi  cally down-
regulate SHP-1 or -2 expression in peritoneal macrophages. (E) Peritoneal macrophages transfected with SHP-1  –   or -2  –  specifi  c siRNAs were stimulated 
with 100 ng/ml LPS for 12 h, and the production of TNF     and IL-6 was determined using ELISA. Data are presented as the mean      the SEM of 3  –  6 inde-
pendent experiments. *, P   	   0.05; **, P   	   0.01 (SHP-1 or SHP2 siRNA different from negative control siRNA). (F) IFN-     production after LPS challenge in 
peritoneal macrophages. 3      10 5   cells/well transfected with SHP-1  –   or -2  –  specifi  c siRNAs was analyzed as in E. *, P   	   0.05; **, P   	   0.01 (SHP-1 or -2 
siRNA different from negative control siRNA). (G) Peritoneal macrophages transfected with SHP-1 or -2 siRNAs or negative control oligonucleotides were 
stimulated with 10 ng/ml of LPS for the indicated times. Cell lysates were blotted with the indicated antibodies. (H) Peritoneal macrophages were trans-
fected with SIRP   -specifi  c siRNA alone or together with SHP-1  –   or -2  –  specifi  c siRNAs with subsequent LPS stimulation. The production of TNF     and IL-6 
were determined as described in E. *, P   	   0.05; **, P   	   0.01  (SIRP1   /SHP-1 or SHP-2 double-knockdown is different from SIRP1     knockdown  alone). 
(I) Rescue of cytokine production by reintroduction of WT SIRP    . 2      10 6   cells/well  SIRP   -KD cells transfected with GFP, WT SIRP     (WT), or its mutant form 
SIRP    -4F (4F) were treated with 100 ng/ml LPS. The amounts of secreted TNF     and IL-6 in supernatants were determined by ELISA as described in E. Data are 
the mean      the SEM of three independent experiments. **, P   	   0.01 (WT different from GFP).     2728 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
during TLR activation. First, LPS-induced SIRP     down-reg-
ulation is required for the initiation of macrophage responses 
because introduction of SIRP     induces inability to respond 
to LPS in RAW cells, whereas depletion of SIRP     results in 
hypersusceptibility to LPS. Second, the SIRP    -mediated in-
hibition of TLR signal functions independently of endotoxin 
tolerance mechanisms, which is consistent with the rapid and 
sustained decrease in SIRP     levels after LPS challenge. Thus, it 
appears that SIRP     is not a component of a feedback regula-
tory system of innate immunity. Instead, SIRP     more likely 
operates at an early  “  time window ”   of TLR-induced responses. 
Third, depletion of SIRP     causes a substantial induction of 
proinfl  ammatory cytokine expression upon LPS exposure, 
whereas most antiinfl  ammatory cytokines are not considerably 
aff  ected. Compared with the release of proinfl  ammatory cyto-
kines, which occurs rapidly after TLR stimulation, production 
of antiinfl  ammatory cytokines is considerably slower. This 
further indicates that SIRP    -mediated repression is an early 
signaling event during TLR activation. Finally, LPS-induced 
activation of the MAPKs and NF-    B pathways is reversely 
proportional to SIRP     expression level, which strongly sug-
gests that the negative regulation of TLR signals by SIRP     
may occur at a receptor-proximate level upstream of multiple 
signaling pathways. Given all the evidence obtained so far, our 
results raise the possibility that the expression level of SIRP     
may represent a threshold factor for septic shock. 
SIRP     and SHP-1 in suppressing LPS signaling. Conversely, 
knockdown of SHP-2 nearly reversed the hyperresponsive 
eff  ects induced by SIRP     depletion in response to LPS, 
which indicate that SIRP     mainly functions through its asso-
ciation and sequestration of SHP-2 to prevent LPS-induced 
macrophage activation. In addition, transient overexpression 
of WT SIRP     into SIRP    -knockdown RAW cells restrained 
LPS-induced cytokine production, whereas its mutant form, 
SIRP    -4F, which is incapable of binding to SHP-2, was 
unable to restore SIRP    -mediated repression of LPS-induc-
ible cytokine genes (  Fig. 6 I  ). These data further indicate that 
SIRP     acts via SHP-2 sequestration to negatively regulate 
TLR4 signaling. 
  SIRP     prevents LPS responses through sequestration 
of SHP-2 from IKKs 
  As a previous study indicates that SHP-2 is an integral compo-
nent of the IKK complex, and a functional SHP-2 is required 
for effi   cient phosphorylation of I    B by the IKK complex in 
cellular response to IL-1/TNF (  26  ), we next searched for phys-
ical evidence for SHP-2 involvement in the MyD88 and Trif 
pathways by coimmunoprecipitation experiments. As expected, 
LPS induced interaction of endogenous SHP-2 with IKK     and 
the IKK-like kinase TANK-binding kinase 1 (TBK1)/NAK 
(  Fig. 7 A  ), both of which are critically important for activation 
of MyD88- and Trif-dependent signaling, respectively (  27, 28  ).   
In contrast, SHP-1 could not be found in a complex with IKK 
(not depicted). Interestingly, compared with empty vector-
transfected RAW cells, SIRP    knockdown drastically enforced 
LPS-induced SHP-2 –  IKK association ( Fig. 7 B ), which strongly 
suggests that SIRP     may compete with IKKs to bind SHP-2, 
thus compromising the essential role of SHP-2 in LPS signal-
ing activation. 
    DISCUSSION   
  A dynamic balance between activation and repression of the 
innate immunity is of critical importance in the host immuno-
logical defenses. Under conditions of LPS exposure, multiple 
feedback mechanisms exist for restraining the strength and 
duration of the transduced signals, and the production of in-
fl  ammatory cytokines, which include the down-regulation of 
surface TLR expression, transcriptional induction of negative 
regulators such as IL-1 receptor  –  associated kinase (IRAK-M), 
suppressor of cytokine signaling 1 (SOCS1), SH2-containing 
inositol phosphatase, MyD88s, and antiinfl  ammatory cytokines, 
mainly IL-10 and TGF-     (  20  ). Although these mechanisms 
probably play a prominent role in termination of TLR signals, 
the factors that restrict initiation of TLR-mediated responses 
remain largely unknown. Our results demonstrate that SIRP     
also acts as a crucial negative regulator of the innate immune 
responses both in vivo and in vitro. However, unlike the in-
duction of other inhibitory proteins, SIRP     is rapidly down-
regulated in response to LPS, which places it in the fi  eld of 
the hitherto poorly understood negative regulatory mechanisms 
dictating the activation of innate immune responses. Multiple 
lines of evidence support such an early inhibitory role of SIRP    
  Figure 7.     SIRP     prevents LPS-induced SHP-2  –  IKK complex formation. 
(A) RAW264.7 cells were treated with 100 ng/ml LPS for the indicated time 
period. Equal amounts of cell lysates were immunoprecipitated with SHP-2 – 
specific antibody. Precipitated proteins and cell lysates were blotted 
with  anti – SHP-2,  anti-IKK   , and anti-TBK1 antibodies. (B) SIRP   -KD,  -OV, 
and -VT RAW cells were stimulated with 100 ng/ml LPS for the indicated 
minutes, immunoprecipitated for endogenous SHP-2, and probed with 
anti-IKK    , -TBK1, and   –  SHP-2 antibodies.     JEM VOL. 204, October 29, 2007 
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However, the molecular basis for SHP  ’  s activities in the NF-kB 
pathway is not yet fully understood. We show that SHP-2, 
but not SHP-1 (not depicted), forms an inducible complex with 
IKK     or TBK1 upon stimulating TLR4 with LPS, which 
appears to be required for NF-    B and IRF3 activation, as the 
enforced SHP-2  –  IKK associations after SIRP     knockdown 
are accompanied by the increased phosphorylation of I    B     
and IRF3. Because SIRP     preferentially associates with, and 
most probably sequesters, SHP-2, which is required for both 
MAPK and IKK activities, it most likely acts at the level of this 
phosphatase to negatively regulate TLR signaling. 
  TLR-induced cytokine production in innate immune cells 
is mediated mainly by MAPK- and IKK-dependent signals. 
By inactivating these two pathways, SIRP     determines the 
window of synthesis of a variety of proinfl  ammatory cytokines, 
including TNF     and IL-6. However, unlike other negative 
regulators, such as IRAK-M or SOCS1, depletion of SIRP     
has no signifi  cant eff  ect on IL-1 and IL-12p40 production after 
LPS challenge (  Fig. 2 C  ), and both IL-1 and IL-12p40 are 
known to contribute to the lethal outcome of endotoxin shock. 
Furthermore, it appears that LPS induces a much more dra-
matic release of TNF     and IL-6 in SIRP    -KD macrophages 
than in IRAK-M  –   or SOCS1-defi  cient macrophages (  33, 34  ). 
These results perhaps refl  ect the diff  erent mechanisms on which 
these regulators operate. Interestingly, it has been shown that 
ligation of SIRP     with monoclonal antibody results in modest 
reduction of TNF     production, possibly via inducing intracel-
lular retention of the cytokine, but has no eff  ect on other cyto-
kine induction in response to LPS stimulation (  35  ), which is 
inconsistent with the broad and drastic augmentation of pro-
infl  ammatory cytokines in SIRP    -depleted macrophages after 
LPS challenge. Considering that both MAPKs and IKKs posi-
tively regulate TNF     synthesis (  36, 37  ), knockdown of SIRP     
may mainly enhance both the stability and the translation of 
TNF     mRNA, rather than modulate its secretion. It has been 
suggested that SIRP     ligation may trigger signal cascades other 
than MPAKs or IKKs; e.g., the PI3K pathway to specifi  cally 
reduce TNF     release. In addition, SIRP     ligation has also been 
shown to induce macrophages to produce NO, thus indicating 
a positive eff  ect of SIRP     (  23  ). However, the level of H  2  O  2   is 
increased after SIRP     ligation, and is found to be essential for 
the SIRP    -induced production of NO, so it is diffi   cult to dis-
tinguish between eff  ects that result from a direct activation of 
SIRP     signaling or an indirect activation as a consequence of 
increased ROS production, or both. Future studies should elu-
cidate more precisely whether and how these pathways inte-
grate and translate into the various cellular functions that are 
regulated by SIRP     in macrophages and other cells. 
  In summary, we have shown that SIRP     plays a critically 
negative role in macrophage activation. LPS-induced SIRP     
down-regulation is required for inducing optimal strength 
and duration of the TLR signaling. SIRP     therefore func-
tions as a   “  homeostatic  ”   eff  ector in innate immunity. The 
basal level of SIRP     in macrophages may represent a thresh-
old for maintaining a non-/antiinfl  ammatory environment. 
SIRP     is likely to become a rational pharmacological target for 
  A notable feature of SIRP     is its ability to recruit and sig-
nal via the tyrosine phosphatases SHP-1 and -2. Therefore, it 
is likely that this feature is important for the negative regula-
tory role of SIRP     in LPS-activated signaling. Although 
structurally very similar, these two phosphatases play quite 
diff  erent cellular roles. SHP-1 has been generally considered 
as a negative signal transducer, essentially as an antagonist of 
SHP-2. The data presented here suggests that SHP-1 plays a rel-
atively minor role in suppressing LPS-induced TLR activation, 
which is consistent with a recent study that SHP-1 modestly 
inhibits LPS-mediated TNF     and iNOS production in mouse 
macrophages ( 29  ). As double-knockdown of SHP-1 and SIRP    
induced a little more cytokine production than knockdown of 
SIRP     alone, SHP-1 may represent a collaborating event in 
SIRP    -mediated negative regulation of TLR signaling. On the 
other hand, our data provide direct evidence that SHP-2 plays a 
largely positive-signaling role in macrophage activation by LPS. 
By analyzing immune responses in macrophages lacking both 
SHP-2 and SIRP     expression, we propose a model in which 
SIRP     plays reciprocating roles in the temporal regulation of 
both pro- and antiinfl  ammatory responses. In the initial phase 
of activation, macrophages have relatively high levels of 
SIRP     protein, which probably acts as a scaff  olding molecule 
to recruit SHP-2 in the vicinity of the cell membrane, thus 
preventing SHP-2 from activating downstream signaling 
pathways. Subsequently, the decrease in SIRP     levels causes 
a disassociation of SHP-2 with SIRP    , thus making SHP-2 
available to mediate TLR signaling activation. 
  All TLRs are known to elicit conserved infl  ammatory 
pathways, culminating in the activation of two major kinase-
mediated signaling pathways: the MAPK and IKK complexes, 
which transduce various upstream signals to the activation of 
AP-1, NF-    B, and IRF3 transcription factors. Both SHP-1 
and -2 have been shown to be necessary for growth factor  – 
induced MAPK activation (  30  ). However, whether SHP-1 and 
-2 regulate LPS-induced MAPK activation remains unknown. 
By knocking down the expression of SHP-1 and -2, we dem-
onstrate that SHP-1 exerts inhibitory eff  ects on MAPK activa-
tion, which is inconsistent with the observation that ERK 
activation occurred normally in mev/mev cells in response to 
LPS (  17  ). It is likely that experimental variations in these ex-
periments explain the diff  ering results. In contrast, SHP-2 is 
seemingly indispensable for MAPK activation, as depletion of 
SHP-2 reduces macrophage responses to LPS. Previously, the 
eff  ects of SIRP     on growth factor  –  induced MAPK activa-
tion in epithelial or fi  broblast cells have been controversially 
reported (  15  ). We clearly show that SIRP     negatively regu-
lates LPS-induced MAPK activation in macrophages. Given 
that SHP-1 is highly expressed in macrophages and, at a much 
lower level, in epithelial or fi  broblast cells, whereas SHP-2 
is expressed in the opposite manner, it is possible that the 
dynamic interaction of SIRP     with SHP-1 and -2 is crucial 
for proper regulation of the MAPKs by LPS or some growth 
factors in cells derived from diff  erent tissues. In addition to 
MAPKs, the NF-    B pathway is also regulated either posi-
tively by SHP-2 (  26, 31  ) or negatively by SHP-1 (  18, 32  ). 2730 SIRP     NEGATIVELY REGULATES LPS SIGNALING | Kong et al.
  Cytokine assay.     Cytokine levels in culture supernatants or in sera were 
determined using commercial ELISA kits for TNF    , IL-6 (R  &  D Systems 
and BD Biosciences), RANTES, MIP-1    , and IFN     (Biosource) according 
to the manufacturer  ’  s instructions. Each value represents the mean of tripli-
cate values. Comprehensive analysis of cytokine levels were performed by 
using commercially available RayBio Mouse Infl  ammation Antibody Array 1.1 
(RayBiotech, Inc.) according to manufacturer  ’  s protocol. 
  Nitrite oxidant detection.     Cells plated at 1.5      10  5   cells/well in 24-well 
culture dishes were incubated overnight before stimulation. After the cells 
were treated with 100 ng/ml LPS for 24 h, culture medium was collected for 
analysis by the Griess Reagent kit. Nitrite concentrations were determined 
by the measurement of the optical density at 570 nm. 
  Luciferase assay.     SIRP    -KD/-OV/-VT RAW264.7 macrophages were 
plated at 5    10  4   cells/well in 48-well culture dishes and were transfected 
with 0.2     g NF-    B-Luc, AP-1-Luc, or ISRE-Luc reporter plasmids to-
gether with 0.02     g of pRL-TK (Promega) by GENEPORTER (Genlantis). 
Luciferase activity was detected by Dual-Luciferase Reporter Assay System 
(Promega). Relative luciferase activity was normalized with Renilla lucifer-
ase activity. 
  RT-PCR.     RNA was extracted from RAW264.7 cells by using Trizol Reagent 
(Invitrogen). 2     g cellular RNA was used for cDNA synthesis. For real-time 
PCR, we used the specifi  c SYBR-Fluo from TaKaRa Biotechnology Co. Ltd. 
PCR primers for detecting mRNA of SIRP     and     -actin were synthesized 
by TaKaRa (Biotechnology Co., Ltd.). PCR reaction consisted of 95  °  C for 
1 min, 57  °  C for 1 min, 72  °  C for 1 min,     35 cycles for both     -actin and SIRP    . 
Primer sequences were as follows:     -actin, sense, 5    -GGACTCCTATGT-
GGGTGGCGAGG-3    , antisense, 5    -GGGAGAGCATGCCCTCGTA-
GAT-3    ; and SIRP    , sense, 5    -TCGAGTGATCAAGGGAGCAT-3    , 
antisense, 5    -CCTGGACACTAGCATACTCTGAG-3    . 
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    MATERIALS AND METHODS   
  Antibodies and reagents.    Antibodies specifi  c for phosphorylated JNK, p38, 
and ERK, as well as total ERK, JNK, p38, and Myc-tag, were all purchased from 
Cell Signaling Technology; anti  –  phospho-I    B    , I    B    , SHP-1, and SHP-2 
antibodies were obtained from Santa Cruz Biotechnology. Rabbit polyclonal 
SIRP     antibody was generated in our laboratory against residues in the cyto-
plasmic domain. Mouse infl  ammation cytokine antibody arrays were purchased 
from RayBiotech, Inc. LPS was purchased from Sigma-Aldrich. The CpG 
oligodeoxynucleotides1826 was purchased from InvivoGen. Vector-based 
shRNAs containing target sequences of AAGTGAAGGTGACTCAGCCTG 
and AATCAGTGTCTGTTGCTGCTG of SIRP     were constructed using 
the pSUPER-neo vector (OligoEngine) according to the manufacturer  ’  s 
protocol. Predesigned phosphorothioate-modifi  ed stealthTM RNA targeted 
against SIRP    , SHP-1, and SHP-2 were provided by Invitrogen, with the 
following sequences: SIRP    : D10, 5    -AAGUGAAGGUGACUCAGC-
CUGAGAA-3    , D12, 5    -CAAAGCCGGCUGUUGAUCUACAGUU-3    ; 
SHP-1: F01, 5    -CCCUCUCAGUCAGGGUGGAUGAUCA-3    , F03, 
5    -GAGAUGGCACCAUCAUCCACCUUAA-3    ; F05, 5    -GAGAACAC  U-
CGUGUCAUCGUCAUGA-3    ; SHP-2: E01, 5    -GAGGGAAGAGCAAA-
UGUGUCAAGUA-3    , E03, 5    -CAGACAGAAGCACAGUACCGGUUUA-3    , 
E05, 5    -AAGUAUUCCUUGGUGGACCAGACAA-3    . 
  Animals.     Male C57BL/6 and BALB/c mice (6  –  8 wk old, weighing 16  –  20 g) 
were obtained from the Shanghai Experimental Center, (Chinese Science 
Academy, Shanghai, China) and maintained at an animal facility under 
pathogen-free conditions. Male WT (C3H/HeOuj and C57BL/10SnJ), 
TLR4 mutant (C3H/HeJ; Pro712-His712), and TLR4-defi  cient (KO; 
C57BL/10ScCr) mice were obtained from the Model Animal Research 
Center of Nanjing University (Nan Jing, China; 8  –  12 wk old). All animals 
received human care according to the criteria outlined in the Guide for the 
Care and Use of Laboratory Animals, which was prepared by the National 
Academy of Sciences and published by the National Institutes of Health 
(publication 86  –  23; revised 1985). 
  Cell lines and isolation of peritoneal macrophages.     Mouse macro-
phage cell lines RAW264.7 and J774A.1 were obtained from the Shanghai 
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